ferric citrate
ferric citrate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Auryxia. Available dosage form: tablet, film coated.
Drug details
- Generic Name
- ferric citrate
- Brand Names
- Auryxia
- Application Number
- NDA205874
- Sponsor
- Akebia Therapeutics, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- TETRAFERRIC TRICITRATE DECAHYDRATE
Indications and Usage
1 INDICATIONS AND USAGE Auryxia is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. ( 1 ) Auryxia is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis. ( 1 ) 1.1 Hyperphosphatemia in Chronic Kidney Disease on Dialysis Auryxia is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. 1.2 Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis Auryxia is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.